1240. Clostridium difficile
Session: Poster Discussion Round: Clostridium difficile
Friday, October 9, 2015: 12:30 PM
Room: Poster Hall
Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA, edubberk@im.wustl.edu, St. Louis, MO


Disclosures:

E. R. Dubberke, rebiotix: Consultant and Investigator , Consulting fee and Research support
sanofi-pasteur: Grant Investigator , Research grant
pfizer: Consultant , Consulting fee
Merck: Consultant and Investigator , Consulting fee and Research support

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.